Genetic and environmental interactions in lung diseases
More details
Hide details
1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, “SOTIRIA” Hospital for Chest Diseases, Athens, Greece
Petros Bakakos   

1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, “SOTIRIA” Hospital for Chest Diseases, Athens, Greece, 11 Kononos St., 11634 Athens, Greece
Pneumon 2012;25(1):64–69
Weiss ST. What genes tell us about the pathogenesis of asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010; 181: 1170-1173.
Yang IA, Fong KM, Holgate ST, Holloway JW. The role of Toll-like receptors and related receptors of the innate immune system in asthma. Curr Opin Allergy Clin Immunol 2006; 6: 23-28.
Mangiarini L, Sathasivam K, Seller M, et al. Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice. Cell 1996; 87: 493-506.
Brockdorff N, Cross GS, Cavanna JS, et al. The mapping of a cDNA from the human X-linked Duchenne muscular dystrophy gene to the mouse X chromosome. Nature 1987; 328: 166-168.
Morahan G, Huang D, Tait BD, Colman PG, Harrison LC. Markers on distal chromosome 2q linked to insulin-dependent diabetes mellitus. Science 1996; 272: 1811-1813.
Levy-Lahad E, Wasco W, Poorkaj P, et al. Candidate gene for the chromosome 1 familial Alzheimer’s disease locus. Science 1995; 269: 973-977.
Jackson SH, Gallin JI, Holland SM. The p47phox mouse knockout model of chronic granulomatous disease. J Exp Med 1995; 182: 751-758.
Jacob CO, Mykytyn K, Varcony T, Drabkin HA. Mapping of the interleukin-5 receptor gene to human chromosome 3p25-p26 and to mouse chromosome 6 close to the Raf-1 locus with polymorphic tandem repeat sequences. Mamm Genome 1993; 4: 435-443.
Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW. Structure of the mouse IL-10 gene and chromosomal localization of the mouse and human genes. J Immunol 1992; 148: 3618-3623.
Silverman EK. Progress in chronic obstructive pulmonary disease genetics. Proc Am Thorac Soc 2006; 3: 405-408.
Adcock IM, Ford P, Barnes PJ, Ito K. Epigenetics and airways disease. Respir Res 2006; 7: 21.
Feinberg AP. Epigenetics at the epicentre of modern medicine. JAMA 2008; 299: 1345-1350.
Feinberg AP, Tycko B. The history of cancer epigenetics. Nat Rev Cancer 2004; 4: 143-153.
Gal-Yam EN, Saito Y, Egger G, Jones PA. Cancer epigenetics: modifications, screening, and therapy. Annu Rev Med 2007; 59: 267-280.
Schwartz DA. Epigenetics and environmental lung disease. Proc Am Thorac Soc 2010; 7: 123-125.
Bibikova M, Chudin E, Wu B, et al. Human embryonic stem cells have a unique epigenetic signature. Genome Res 2006; 16: 1075-1083.
Fraga MF, Ballestar E, Paz MF, et al. Epigenetic differences arise during the lifetime of monozygotic twins. Proc Natl Acad Sci USA 2005; 102: 10604-10609.
Seligson B, Horvarth S, Shi T, et al. Global histone modification patterns predict risk of prostate cancer recurrence. Nature 2005; 435: 1262-1266.
Anway MD, Cupp AS, Uzumcu M, Skinner MK. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 2005; 308: 1466-1469.
Cosio BG, Mann B, Ito K, et al. Histone acetylase and deacetylase activity in alveolar macrophages and blood monocytes in asthma. Am J Respir Crit Care Med 2004; 170: 141-147.
Hollingsworth JW, Maruoka S, Boon K, et al. In utero supplementation with methyl donors enhances allergic airway disease in mice. J Clin Invest 2008; 118: 3462-3469.
Choi JH, Oh SW, Kang MS, Kwon HJ, Oh GT, Kim DY. Trichostatin a attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 2005; 35: 89-96.
Yang IA, Fong KM, Zimmerman PV, Holgate ST, Holloway JW. Genetic susceptibility to the respiratory effects of air pollution. Thorax 2008; 63: 555-563.
Weedon MN, Lango H, Lindgren CM, et al. Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet 2008; 40: 575-583.
Maher B. The case of the missing heritability. Nature 2008; 456: 18-21.
Goldstein DB. Common genetic variation and human traits. N Engl J Med 2009; 360: 1696-1698.
Kleeberger SR. Genetic aspects of susceptibility to air pollution. Eur Respir J 2003; 21: (Suppl 40) 52s-56s.
Brook RD, Franklin B, Cascio W, et al. Air pollution and cardiovascular disease: a statement for healthcare professionals from the expert panel on population and prevention science of the American Heart Association. Circulation 2004; 109: 2655-2671.
Peters A, Greven S, Heid IM, et al. AIRGENE Study Group Fibrinogen genes modify the fibrinogen response to ambient particulate matter. Am J Respir Crit Care Med 2009; 179: 484-491.
Baccarelli A, Wright RO, Bollati V, et al. Rapid DNA methylation changes after exposure to traffic particles. Am J Respir Crit Care Med 2009; 179: 572-578.
Mudway IS, Kelly FJ. Ozone and the lung: a sensitive issue. Mol Aspects Med 2000; 21: 1-48.
Nel A. Atmosphere. Air pollution-related illness: effects of particles. Science 2005; 308: 804-806.
Saxon A, Diaz-Sanchez D. Air pollution and allergy: you are what you breathe. Nat Immunol 2005; 6: 223-226.
Shukla A, Timblin C, BeruBe K, et al. Inhaled particulate matter causes expression of nuclear factor (NF)-kB-related genes and oxidant-dependent NF-kB activation in vitro. Am J Respir Cell Mol Biol 2000; 23: 182-187.
Machado RD, Eickelberg O, Elliott CG, et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: (1 Suppl) 32s-42s.
Newman JH, Trembath RC, Morse JA, et al. Genetic basis of pulmonary arterial hypertension: current understanding and future diredtions. J Am Coll Cardiol 2004; 43: (12 Suppl) 33s-39s.
McCleskey TM, Buchner V, Field RW, Scott BL. Recent advances in understanding the biomolecular basis of chronic beryllium disease: a review. Rev Environ Health 2009; 24: 75-115.
Albihn A, Johnsen JI, Henriksson MA. MYC in oncogenesis and as a target for cancer therapies. Adv Cancer Res 2010; 107: 163-224.
Risch A, Plass C. Lung cancer epigenetics and genetics. Int J Cancer 2008; 123: 1-7.
Clavel J. Progress in the epidemiological understanding of gene-environment interactions in major diseases: cancer. C R Biol 2007; 330: 306-317.
Hirvonen A. Genetic factors in individual responses to environmental exposures. J Occup Environ Med 1995; 37: 37-43.
Gao Y, Goldstein AM, Consonni D, et al. Family history of cancer and non-malignant lung diseases as risk factors for lung cancer. Int J Cancer 2009; 125: 146-152.
Selroos O. Differences in sarcoidosis around the world: what they tell us. In: Baughman RP, ed. Sarcoidosis. New York , Informa 2006; pp47-64.
Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A. HLADRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 2001; 57: 87-90.
Harari S, Caminati A. IPF: new insight on pathogenesis and treatment. Allergy 2010; 65: 537-553.
Steele MP, Brown KK. Genetic predisposition to respiratory diseases: infiltrative lung diseases. Respiration 2007; 74: 601-608.
Thomas AQ, Lane K, Phillips J 3rd et al. Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 2002; 165: 1322-1328.
Grutters JC, du Bois RM. Genetics of fibrosing lung diseases. Eur Respir J 2005; 25: 915-927.
Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2010; 182: 220-229.
Kramnik I. Genetic dissection of host resistance to Mycobacterium tuberculosis: the sst1 locus and the Ipr1 gene. Curr Top Microbiol Immunol 2008; 321: 123-148.
Mahr AD, Neogi T, Merkel PA. Epidemiology of Wegener’s granulomatosis: Lessons from descriptive studies and analyses of genetic and environmental risk determinants. Clin Exp Rheumatol 2006; 24: (Suppl 41) 82s-91s.